Lupin Reaches Quarter-Of-A-Billion Dollar Deal Over Glumetza Antitrust Claims

Antitrust Class Action Filed In 2019; Bausch Health Settled Earlier In September

 
• By Dean Rudge
Gavel
Lupin said it disputed the claims but acknowledged "increased uncertainty." • Source: Shutterstock

More from Deals

More from Business